Startseite » People » PIs » Hristov » Publikationen

Publikationen

Orginalarbeiten

 

1. Weber C, Liehn E, Tuchscheerer N, Kanzler I, Drechsler M, Fraehmos L, Schuh A, Koenen R, Zandler S, Soehnlein O, Hristov M, Grigorescu G, Urs AO, Leabu M, Bucur I, Merx M, Zernecke A, Ehling J, Gremse F, Lammers T, Kiessling F, Bernhagen J, Schober A. Double-edged role of the CXCL12-CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol. 2011; (in press). IF 14,292*

2. Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens RT, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van Zandvoort MA, Binder CJ, Jelinek I, Hristov M, Boon L, Jung S, Korn T, Lutz MB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J Clin Invest. 2011; 121: 2898-910. IF 14,152*

3. Schober A#, Hristov M#, Kofler S#, Forbrig R, Löhr B, Heussen N, Zhe Z, Akhtar S, Krötz F, Schumann U, Leibig M, König A, Kaczmarek I, Reichart B, Klauss V, Weber C, Sohn HY. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy. Eur Heart J. 2011; 32: 476-84. #equal contribution IF 10,046*

4. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G. Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med. 2011; 15: 668-78. IF 4,608*

5. Felker P, Seré K, Lin Q, Becker C, Hristov M, Hieronymus T, Zenke M. TGF-{beta}1 accelerates dendritic cell differentiation from common dendritic cell progenitors and directs subset specification toward conventional dendritic cells. J Immunol. 2010; 185: 5326-35. IF 5,745*

6. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Müller-Newen G, Soehnlein O, Weber C. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation. 2010; 122: 495-506. IF 14,429*

7. Hristov M, Leyendecker T, Schuhmann C, von Hundelshausen P, Heussen N, Kehmeier E, Krötz F, Sohn HY, Klauss V, Weber C. Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease. Thromb Haemost. 2010; 104: 412-4. IF 4,701* (Editorial focus by Shantsila et al.)

8. Hristov M, Gumbel D, Lutgens E, Zernecke A, Weber C. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury. Circulation. 2010; 121: 315-24. IF 14,429* (Editorial focus by J. Rehman)

9. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2: ra81. IF 6,120

10. Hristov M, Schmitz S, Schuhmann C, Leyendecker T, von Hundelshausen P, Krötz F, Sohn HY, Nauwelaers F, Weber C. An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood. Cytometry A. 2009; 75: 848-53. IF 3,749

11. Malycha F, Eggermann T, Hristov M, Schena FP, Mertens PR, Zerres K, Floege J, Eitner F. No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients. Nephrol Dial Transplant. 2009; 24: 321-4. IF 3,564

12. Redondo S, Hristov M, Gordillo-Moscoso AA, Ruiz E, Weber C, Tejerina T. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population. J Immunol Methods. 2008; 335: 21-7. IF 2,347

13. Schlieper G#, Hristov M#, Brandenburg V, Krüger T, Westenfeld R, Mahnken AH, Yagmur E, Boecker G, Heussen N, Gladziwa U, Ketteler M, Weber C, Floege J. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant. 2008; 23: 2611-8. #equal contribution IF 3,306

14. Postea O, Koenen RR, Hristov M, Weber C, Ludwig A. Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo. J Cell Mol Med. 2008; 12: 1700-9. IF 5,228

15. Shagdarsuren E, Bidzhekov K, Djalali-Talab Y, Liehn EA, Hristov M, Matthijsen RA, Buurman WA, Zernecke A, Weber C. C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation. 2008; 117: 70-8. IF 14,816

16. Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, Merx MW, Weber C. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model. Basic Res Cardiol. 2008; 103: 69-77. IF 5,973

17. Karshovska E, Zernecke A, Sevilmis G, Millet A, Hristov M, Cohen CD, Schmid H, Krötz F, Sohn HY, Klauss V, Weber C, Schober A. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol. 2007; 27: 2540-7. IF 6,858

18. Redondo S, Hristov M, Gümbel D, Tejerina T, Weber C. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1. Thromb Haemost. 2007; 97: 979-87. IF 3,803

19. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, Weber C. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res. 2007; 100: 590-7. IF 9,989

20. Hristov M, Fach C, Becker C, Heussen N, Liehn EA, Blindt R, Hanrath P, Weber C. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis. 2007; 192: 413-20. IF 4,601

21. Hristov M, Heussen N, Schober A, Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med. 2006; 10: 727-33. IF 6,807

22. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol. 2006; 47: 1786-95. IF 11,054

23. Hristov M, Erl W, Linder S, Weber PC. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood. 2004; 104: 2761-6. IF 10,131 (Editorial focus by D. Sane)

24. Erl W, Hristov M, Neureuter M, Yan ZQ, Hansson GK, Weber PC. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis. 2003; 169: 251-8. IF 3,796

 

 

Übersichten

 

1. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost. 2011; 106: 757-62. IF 4,701*

2. Soehnlein O, Drechsler M, Hristov M, Weber C. Functional alterations of myeloid cell subsets in hyperlipidemia: relevance for atherosclerosis. J Cell Mol Med. 2009; 13: 4293-303. IF 4,608

3. Hristov M, Weber C. Progenitor cell trafficking in the vascular wall. J Thromb Haemost. 2009; Suppl 1: 31-4. IF 5,439

4. Hristov M, Weber C. Endothelial progenitor cells: cellular biomarkers in vascular disease. Drug Discov Today. 2008; 5: e267-e271. IF 6,630

5. Hristov M, Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Curr Opin Lipidol. 2008; 19: 491-7. IF 6,133

6. Hristov M, Weber C. Endothelial progenitor cells in vascular repair and remodeling. Pharmacol Res. 2008; 58: 148-51. IF 3,929

7. Hristov M, Zernecke A, Schober A, Weber C. Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem. 2008; 389: 837-44. IF 2,732

8. Hristov M, Zernecke A, Liehn EA, Weber C. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost. 2007; 98: 274-7. IF 3,803

9. Hristov M, Keymel S, Weber C. The therapeutic effect of autologous bone marrow cells in ischemic heart disease. Med Klin (Munich). 2006; 101 Suppl 1: 186-9. IF 0,284

10. Hristov M, Weber C. The therapeutic potential of progenitor cells in ischemic heart disease -- Past, present and future. Basic Res Cardiol. 2006; 101: 1-7. IF 4,333

11. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004; 8: 498-508. IF 3,606

12. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med. 2003; 13: 201-6. IF 4,716

13. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol. 2003; 23: 1185-9. IF 7,432

 

*Der IF für 2010/11 ist als Richtwert angegeben und basiert auf der aktuellen Journal Citation Reports Datenbank.

 
 
IPEKlogo

Direktor:

Prof. Dr. med. Christian Weber

 

Institute for Cardiovascular Prevention (IPEK)

 

Pettenkoferstraße 8a & 9

80336 München

 

Tel.: 089-4400-54351

Fax: 089-4400-54352

Mail: ipek.office@med.lmu.de